A Study to Evaluate the Safety and Pharmacokinetics of Regadenoson in Pediatric Patients

NCT04604782 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

54

Enrollment

INDUSTRY

Sponsor class

Conditions

Myocardial Ischemia
Coronary Artery Disease

Interventions

DRUG: Regadenoson

Sponsor

GE Healthcare

Collaborators

[object Object]